Bank Analysts Say Pfizer-AstraZeneca Merger Still Makes Sense CHAD BRAY Two BNP Paribas analysts said in a research note that a sweetened offer of about $127.7 billion by Pfizer for its British rival would still make “economic sense.” June 24, 2014 at 4:00AM http://nyti.ms/1wrI8gT The New York Times Business Day Drugs (Pharmaceuticals), Federal Taxes (US), Mergers, Acquisitions and Divestitures, Stocks and Bonds

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1wrI8gT Bank Analysts Say Pfizer-AstraZeneca Merger Still Makes Sense June 24, 2014 at 4:00AM The New York Times